Neural substrates of cue reactivity: association with treatment outcomes and relapse KE Courtney, JP Schacht, K Hutchison, DJO Roche, LA Ray Addiction biology 21 (1), 3-22, 2016 | 214 | 2016 |
Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: a randomized, placebo-controlled, human laboratory trial LA Ray, S Bujarski, S Shoptaw, DJO Roche, K Heinzerling, K Miotto Neuropsychopharmacology 42 (9), 1776-1788, 2017 | 111 | 2017 |
Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co-and tri-use DJO Roche, S Bujarski, R Green, EE Hartwell, AM Leventhal, LA Ray Drug and alcohol dependence 200, 40-49, 2019 | 99 | 2019 |
Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women DJO Roche, AC King, AJ Cohoon, WR Lovallo Pharmacology Biochemistry and Behavior 109, 84-90, 2013 | 89 | 2013 |
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? LA Ray, S Bujarski, MM Yardley, DJO Roche, EE Hartwell The American journal of drug and alcohol abuse 43 (6), 703-710, 2017 | 75 | 2017 |
Subjective response to alcohol as a research domain criterion LA Ray, S Bujarski, DJO Roche Alcoholism: Clinical and Experimental Research 40 (1), 6-17, 2016 | 71 | 2016 |
The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study LA Ray, S Bujarski, KE Courtney, NR Moallem, K Lunny, D Roche, ... Neuropsychopharmacology 40 (10), 2347-2356, 2015 | 66 | 2015 |
Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence DJO Roche, AC King Psychopharmacology 212, 33-44, 2010 | 63 | 2010 |
Opportunities for the development of neuroimmune therapies in addiction LA Ray, DJO Roche, K Heinzerling, S Shoptaw International review of neurobiology 118, 381-401, 2014 | 60 | 2014 |
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study MJ Worley, KG Heinzerling, DJO Roche, S Shoptaw Drug and alcohol dependence 162, 245-250, 2016 | 57 | 2016 |
Varenicline potentiates alcohol‐induced negative subjective responses and offsets impaired eye movements E Childs, DJO Roche, AC King, H de Wit Alcoholism: Clinical and Experimental Research 36 (5), 906-914, 2012 | 51 | 2012 |
Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase DJO Roche, AC King Psychoneuroendocrinology 52, 59-71, 2015 | 49 | 2015 |
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis LA Ray, RJ Green, DJO Roche, M Magill, S Bujarski Addiction biology 24 (6), 1138-1152, 2019 | 46 | 2019 |
Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm S Bujarski, JD Jentsch, DJO Roche, VA Ramchandani, K Miotto, LA Ray Neuropsychopharmacology 43 (9), 1891-1899, 2018 | 46 | 2018 |
The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users S Bujarski, DJO Roche, K Lunny, NR Moallem, KE Courtney, V Allen, ... Drug and alcohol dependence 142, 127-132, 2014 | 43 | 2014 |
Overcoming the “Valley of Death” in medications development for alcohol use disorder LA Ray, S Bujarski, DJO Roche, M Magill Alcoholism: Clinical and Experimental Research 42 (9), 1612-1622, 2018 | 42 | 2018 |
Acute alcohol response phenotype in heavy social drinkers is robust and reproducible DJO Roche, MD Palmeri, AC King Alcoholism: Clinical and Experimental Research 38 (3), 844-852, 2014 | 41 | 2014 |
Factor structure of subjective responses to alcohol in light and heavy drinkers S Bujarski, KE Hutchison, DJO Roche, LA Ray Alcoholism: clinical and experimental research 39 (7), 1193-1202, 2015 | 40 | 2015 |
Current insights into the mechanisms and development of treatments for heavy-drinking cigarette smokers DJO Roche, LA Ray, MM Yardley, AC King Current addiction reports 3, 125-137, 2016 | 38 | 2016 |
Acute HPA axis response to naltrexone differs in female vs. male smokers DJO Roche, E Childs, AM Epstein, AC King Psychoneuroendocrinology 35 (4), 596-606, 2010 | 38 | 2010 |